First Trust Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.58M | Sell |
162,565
-136,907
| -46% | -$2.38M | ﹤0.01% | 1644 |
|
|
2025
Q4 | $3.53M | Buy |
299,472
+189,946
| +173% | +$2.44M | ﹤0.01% | 1606 |
|
|
2025
Q3 | $1.73M | Sell |
109,526
-454,665
| -81% | -$6.59M | ﹤0.01% | 1898 |
|
|
2025
Q2 | $6.46M | Buy |
564,191
+207,092
| +58% | +$2.33M | 0.01% | 1241 |
|
|
2025
Q1 | $4.83M | Sell |
357,099
-139,156
| -28% | -$2.31M | ﹤0.01% | 1328 |
|
|
2024
Q4 | $8.39M | Buy |
496,255
+104,506
| +27% | +$2.03M | 0.01% | 1118 |
|
|
2024
Q3 | $7.96M | Buy |
391,749
+90,493
| +30% | +$1.85M | 0.01% | 1119 |
|
|
2024
Q2 | $6.8M | Buy |
301,256
+188,199
| +166% | +$4.93M | 0.01% | 1141 |
|
|
2024
Q1 | $2.97M | Sell |
113,057
-16,843
| -13% | -$480K | ﹤0.01% | 1555 |
|
|
2023
Q4 | $4.1M | Sell |
129,900
-383,646
| -75% | -$10.4M | ﹤0.01% | 1377 |
|
|
2023
Q3 | $14.4M | Sell |
513,546
-180,732
| -26% | -$6.21M | 0.02% | 871 |
|
|
2023
Q2 | $25.6M | Sell |
694,278
-798,188
| -53% | -$24.4M | 0.03% | 644 |
|
|
2023
Q1 | $44.7M | Buy |
1,492,466
+109,667
| +8% | +$3.61M | 0.05% | 468 |
|
|
2022
Q4 | $42.3M | Sell |
1,382,799
-172,922
| -11% | -$5.19M | 0.05% | 483 |
|
|
2022
Q3 | $38.3M | Sell |
1,555,721
-187,319
| -11% | -$6.18M | 0.05% | 491 |
|
|
2022
Q2 | $55.8M | Buy |
1,743,040
+428,752
| +33% | +$15.8M | 0.07% | 420 |
|
|
2022
Q1 | $41.4M | Buy |
1,314,288
+895,847
| +214% | +$28M | 0.04% | 542 |
|
|
2021
Q4 | $14M | Sell |
418,441
-298,633
| -42% | -$9.3M | 0.01% | 952 |
|
|
2021
Q3 | $20.8M | Buy |
717,074
+148,257
| +26% | +$4.8M | 0.02% | 764 |
|
|
2021
Q2 | $19.8M | Buy |
568,817
+454,806
| +399% | +$15.1M | 0.02% | 782 |
|
|
2021
Q1 | $3.18M | Sell |
114,011
-46,308
| -29% | -$1.23M | ﹤0.01% | 1523 |
|
|
2020
Q4 | $3.97M | Buy |
160,319
+89,432
| +126% | +$2.13M | 0.01% | 1200 |
|
|
2020
Q3 | $1.48M | Sell |
70,887
-95,144
| -57% | -$1.84M | ﹤0.01% | 1539 |
|
|
2020
Q2 | $2.55M | Sell |
166,031
-174,203
| -51% | -$2.2M | ﹤0.01% | 1265 |
|
|
2020
Q1 | $3.02M | Sell |
340,234
-268,010
| -44% | -$3.86M | 0.01% | 1079 |
|
|
2019
Q4 | $11M | Buy |
608,244
+429,442
| +240% | +$7.13M | 0.02% | 807 |
|
|
2019
Q3 | $2.67M | Buy |
178,802
+40,368
| +29% | +$657K | 0.01% | 1362 |
|
|
2019
Q2 | $3.32M | Buy |
138,434
+20,764
| +18% | +$612K | 0.01% | 1293 |
|
|
2019
Q1 | $4.37M | Buy |
117,670
+33,696
| +40% | +$1.23M | 0.01% | 1095 |
|
|
2018
Q4 | $2.37M | Sell |
83,974
-9,607
| -10% | -$304K | 0.01% | 1380 |
|
|
2018
Q3 | $3.69M | Sell |
93,581
-298,519
| -76% | -$13.1M | 0.01% | 1310 |
|
|
2018
Q2 | $17.4M | Sell |
392,100
-234,602
| -37% | -$11.7M | 0.04% | 620 |
|
|
2018
Q1 | $30.5M | Sell |
626,702
-16,984
| -3% | -$849K | 0.07% | 353 |
|
|
2017
Q4 | $32.2M | Buy |
643,686
+286,078
| +80% | +$15M | 0.08% | 330 |
|
|
2017
Q3 | $18.1M | Buy |
357,608
+126,967
| +55% | +$5.99M | 0.05% | 556 |
|
|
2017
Q2 | $8.75M | Buy |
230,641
+67,505
| +41% | +$2.66M | 0.02% | 795 |
|
|
2017
Q1 | $6.28M | Buy |
163,136
+55,427
| +51% | +$1.67M | 0.02% | 953 |
|
|
2016
Q4 | $2.38M | Sell |
107,709
-19,593
| -15% | -$402K | 0.01% | 1335 |
|
|
2016
Q3 | $2.04M | Buy |
+127,302
| New | +$1.45M | 0.01% | 1328 |
|
|
2016
Q1 | – | Sell |
-795,983
| Closed | -$4.27M | – | 2223 |
|
|
2015
Q4 | $4.27M | Buy |
+795,983
| New | +$5.09M | 0.01% | 1028 |
|
Other funds holding CC
VPM
VCM
WHCM
First Trust Advisors's CC Position: Q1 2026 in Review
First Trust Advisors reduced its Chemours (CC) stake by 46% in Q1 2026, selling an estimated $2.38M and leaving 162,565 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1644.
First Trust Advisors first reported a position in CC in Q4 2015 and has held it in 40 quarters since. The position peaked at $55.8M in Q2 2022. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- First Trust Advisors held 162,565 shares of Chemours worth $3.58M as of Q1 2026.
- First Trust Advisors sold 136,907 Chemours shares in Q1 2026, an estimated $2.38M.
- Chemours made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #1644 holding.
- First Trust Advisors first reported a position in Chemours in Q4 2015 and has held it in 40 quarters since.
- First Trust Advisors's Chemours position peaked at $55.8M in Q2 2022.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.